Management Consulting

Corporate Strategy Planning

Aligning your business with your goals

When you partner with Alira Health, we’ll deliver full spectrum support from our team of global specialists. You’ll benefit from a comprehensive industry evaluation, complete with local market condition assessment. Together, we’ll review your company operations and create a short- and long-term plan to align them with your mission, values, goals and vision.

Creating a tailored, focused plan for the future

The complex nature of the healthcare and life sciences landscape demands intentional long-range planning. The attrition and costs of the industry favor companies who dedicate resources to creating strategies that provide detailed operational activities to meet their long-term goals.
That's why, as your partner, Alira Health creates a plan tailored for your business with four objectives in mind:
  • Formalizing your business vision and long-term ambition
  • Outline the full spectrum of scenarios that may take place
  • Define a set of assumptions and review the impact of changes
  • Align employees around the company’s long-term ambition, defining operational activities and KPIs to support the goals

Why choose Alira Health?

As your partner, Alira Health supports your innovation, optimizing product development success every step of the way. Our integrated, collaborative teams provide a lifecycle approach to delivering our services, including:

  • Regulatory strategy
  • Regulatory intelligence
  • Regulatory operations
  • Clinical
  • Market access
  • Click here to see how we delivered a recent growth opportunity assessment for a leading pharmaceutical company

Connect with a Winning Team

See why Alira Health was named one of the world’s best management consulting firms by Forbes.

Related news

News February 7, 2024
Alira Health Advises Aesculapius Farmaceutici Srl in Its Acquisition by Ceres Pharma NV
We are pleased to have represented as transaction advisor Aesculapius, a leading Italian pharmaceutical company active in the development and distribution of prescription drugs, OTC(...)
Pharma Transaction Advisory
News January 26, 2024
Alira Health’s CDD Supports Alcami Acquisition of Pacific Pharmaceutical Services
We are pleased to have been an advisor on Alcami’s acquisition of Pacific Pharmaceutical Services (PPS). Alira Health advised Alcami, a leading Contract Development Manufacturing(...)
CDD CDMO Pharma
Events January 22, 2024
Pharmapack Europe
Connect with our Drug Delivery Systems and CDMO experts Aude Ouensanga, Giulia Valsecchi, and Michal Raciborski on site at Pharmapack Europe.
CDMO Drug Delivery Pharma
Case Studies January 18, 2024
Pharma Company Succeeds in Adding Medicine to World Health Organization Essential Medicines List
A pharma company with a blood disorder treatment needed support to submit a value dossier to the WHO to add a medicine to the Essential Medicines List.
Market Access Pharma
Case Studies January 8, 2024
Pharma Company Extends to New Markets through Strategic Licensing Agreements
A Swedish pharma company saw a market opportunity to expand access to its proprietary product outside of the Nordics and sought support developing strategic licensing deals.
Market Access Pharma
Blog November 17, 2023
Misconceptions About Patient-Centric Co-Design
Many people have misconceptions about patient-centric co-design, and these misconceptions are holding companies back.
Co-Design Digital Health MedTech Patient Centricity Pharma
Blog November 2, 2023
The Impact of New Treatment Approvals in Oncology on Relative Survival Rates for EU Patients
This article explores the relationship between the number of new cancer treatment approvals and the five-year relative survival of cancer patients across the European Union (EU).
Oncology Pharma
Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.